Skip to main content
SpringerLink
Log in
Book cover

Guidebook for Clinical Psychology Interns pp 171–209Cite as

Psychopharmacology in Clinical Practice

  • Chapter

Part of the book series: Applied Clinical Psychology ((NSSB))

Abstract

Psychopharmacology is the study of natural and synthetic substances (i.e., drugs) that affect cognitive and emotional functioning. Clinical psychopharmacology is an extension of this discipline, and involves the treatment of mental disorders with medication. Due to the many advances in clinical psychopharmacology over the past three decades, a number of mental disorders are now treated with some form of medication. In many cases, these pharmacologic treatments are used in conjunction with psychotherapy, and this combination of treatment modalities has grown increasingly common. As a result, the psychologist often is the primary therapist for patients being treated with medication. In outpatient settings, a psychologist may be the sole person responsible for determining whether to refer a patient for treatment with medication. We believe, therefore, that it is important for clinical psychologists to develop some familiarity with psychopharmacologic agents and the indications for their use.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders (3rd ed. rev.). Washington, DC: Author.

    Google Scholar 

  • Arana, G. W., & Hyman, S. E. (1991). Handbook of psychiatric drug therapy. Boston: Little, Brown.

    Google Scholar 

  • Asberg, M., Cronholm, B., & Sjoquist, F. (1971). Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal, 3:331–334.

    Article  PubMed  Google Scholar 

  • Baldessarini, R. J. (1990). Drugs and the treatment of psychiatric disorders. In A. Goodman Gilman, T. W. Rall, A. S. Nies, & P. Taylor (Eds.), The pharmacological basis of therapeutics (8th ed., pp. 383–435). New York: Pergamon.

    Google Scholar 

  • Baldessarini, R. J., Cohen, B. M., & Teicher, M. H. (1988). Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis. Archives of General Psychiatry, 45, 79–91.

    Article  PubMed  Google Scholar 

  • Bernstein, J. G. (1988). Handbook of drug therapy in psychiatry. Littleton, MA: PGS.

    Google Scholar 

  • Bradwejn, J., Shriqui, C., Koszycki, M. A., & Meterissian, G. (1990). Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. Journal of Clinical Psychopharmacology, 10, 403–408.

    Article  PubMed  Google Scholar 

  • Cade, J. F. J. (1949). Lithium salts in the treatment of psychotic excitement. Medical Journal of Australia, 2, 349–352.

    PubMed  Google Scholar 

  • Chouinard, G., Young, S. N., & Annable, L. (1983). Antimanic effect of clorazepam. Biological Psychiatry, 18, 451–466.

    PubMed  Google Scholar 

  • Chung, H. K. (1981). Schizophrenics fully remitted on neuroleptics for 3–5 years: To stop or continue drugs? British Journal of Psychiatry, 139, 490–494.

    Article  Google Scholar 

  • Clark, W. G., Brater, D. C., & Johnson, A. R. (1988). Goth’s medical pharmacology. St. Louis: C. V. Mosby.

    Google Scholar 

  • Cohen, L. S., Friedman, J. M., Jefferson, J. W., et al. (1994). A reevaluation of risk of in utero exposure to lithium. Journal of the American Medical Association, 271, 146–150.

    Article  PubMed  Google Scholar 

  • Cohen, L. S., Rosenbaum, J. F., & Heller, V. L. (1991). Psychotropic drug use in pregnancy. In A. J. Gelenberg, E. L. Basjuk, & S. C. Schoonover (Eds.), The practitioner’s guide to psychoactive drugs (3rd ed., pp. 389–405). New York: Plenum.

    Chapter  Google Scholar 

  • Delay, J., & Deniker, P. (1952). Trente-huit cas de psychoses traitées par la cure prolongée et continué de 4560 RP. Le Congres des Al. et Neurol. de Langue Fr. In Compte rendu du Congrès. Paris: Masson et Cie.

    Google Scholar 

  • Deniker, P. (1983). Discovery of the clinical use of neuroleptics. In M. J. Parnham & J. Bruinvels (Eds.), Discoveries in pharmacology, Vol. 1. Psycho-and neuro-pharmacology (pp. 163–180). Amsterdam: Elsevier.

    Google Scholar 

  • Devanand, D. P., & Sackheim, H. A. (1990). Electroconvulsive therapy. Efficacy, side effects, and mechanisms of action. In R. Pohl & S. Gershon (Eds.), Biological bases of psychiatric treatment (pp. 170–210). New York: Karger.

    Google Scholar 

  • Elia, J., Katz, I. R., & Simpson, G. M. (1987). Teratogenicity of psychotherapeutic medications. Psychopharmacology Bulletin, 47, 531–586.

    Google Scholar 

  • Fleischhacker, W. W., Roth, S. D., & Kane, J. M. (1990). The pharmacologic treatment of neuroleptic-induced akathisia. Journal of Clinical Psychopharmacology, 10, 12–21.

    Article  PubMed  Google Scholar 

  • Gardner, D. L., & Cowdey, R. W. (1985). Alprazolan-induced dyscontrol in borderline personality disorder. American Journal of Psychiatry, 142, 98–99.

    PubMed  Google Scholar 

  • Garza-Trevino, E. S., Hollister, L. E., Overall, J. E., & Alexander, W. F. (1989). Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. American Journal of Psychiatry, 146, 1598–1601.

    PubMed  Google Scholar 

  • Gelenberg, A. J. (1991). Psychoses. In A. J. Gelenberg & E. L. Bassuk, S. C. Schoonover (Eds.), The practitioner’s guide to psychoactive drugs (3rd ed., pp. 125–178). New York: Plenum.

    Chapter  Google Scholar 

  • Gelenberg, A. J., Bassuk, E. L., & Schoonover, S. C. (Eds.). (1991). Practitioner’s Guide to Psychoactive Drugs (3rd ed.). New York: Plenum.

    Book  Google Scholar 

  • Gelenberg, A. J., Kane, J. M., Keller, M. B., Lavori, P., Rosenbaum, J. F., Cole, K., & Lavelle, J. (1989). Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. The New England Journal of Medicine, 321, 1489–1493.

    Article  PubMed  Google Scholar 

  • Gitlin, J. (1993). Lithium-induced renal insufficiency. Journal of Clinical Psychopharmacology, 13, 276–279.

    PubMed  Google Scholar 

  • Glassman, A. H., Perel, J. M., Shostak, M., Kantor, S. J., Fleiss, J. L. (1977). Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry, 34, 197–204.

    Article  PubMed  Google Scholar 

  • Goodman Gilman, A., Rall, T. W., Nies, A. S., & Taylor, P. (1990). The pharmacological basis of therapeutics (8th ed.). New York: Pergamon.

    Google Scholar 

  • Goodman, W. K., & Charney, D. S. (1985). Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and tricyclic antidepressant drugs. Journal of Clinical Psychiatry, 46 (10 section 2), 6–22.

    PubMed  Google Scholar 

  • Goodwin, F. K., & Jamison, K. R. (1990). Manic-depressive illness. New York: Oxford University Press.

    Google Scholar 

  • Goodwin, F. K., Murphy, D. L., & Bunney, W. E. (1969). Lithium carbonate treatment in depression and mania. Archives of General Psychiatry, 21, 486–496.

    Article  PubMed  Google Scholar 

  • Guyton, A. C. (1991). Textbook of medical physiology (8th ed., pp. 478–494). Philadelphia: W. B. Saunders.

    Google Scholar 

  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurosurgical Psychiatry, 23, 56–61.

    Article  Google Scholar 

  • Jamison, K. R., Gerner, R. H., & Goodwin, T. K. (1981). Patient and physician attitudes toward lithium. Archives of General Psychiatry, 135, 917–922.

    Google Scholar 

  • Janicak, P. G., Bresnahan, D. B., & Comoty, S. E. (1987). The neuroleptic malignant syndrome: A clinical update. Psychiatric Annals, 17, 551–555.

    Google Scholar 

  • Jefferson, J. W., Griest, J. H., & Ackerman, D. L. (1987). Lithium encyclopedia for clinical practice. Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Jeste, D. V., Grebb, J. A., & Wyatt, R. J. (1985). Psychiatric aspects of movement disorders and demyelinating diseases. In R. E. Hales & A. J. Frances (Eds.), APA annual review (Vol. 4, pp. 159–189). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Joyce, P. R., & Paykel, E. S. (1989). Predictors of drug response in depression. Archives of General Psychiatry, 46, 89–99.

    Article  PubMed  Google Scholar 

  • Kane, J. M., Hongfeld, G., Singer, J., & Meltzer, H. (1988). Clozapine for the treatmentresistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.

    Article  PubMed  Google Scholar 

  • Kane, J. M., & Kinon, B. J. (1983). Tardive dyskinesia: A review of current knowledge. In A. R. Rifkin (Ed.), Schizophrenia and affective disorders, biology and drug treatment. Boston: John Wright.

    Google Scholar 

  • Kane, J. M., Rifkin, A., & Quitkin, F. (1982). Fluphenazine versus placebo in patients with remitted, acute first episodes of schizophrenia. Archives of General Psychiatry, 39, 70–73.

    Article  PubMed  Google Scholar 

  • Kane, J. M., Woerner, M., & Borenstein, M. (1986). Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacology Bulletin, 22, 254–258.

    PubMed  Google Scholar 

  • Kocsis, J. H., Frances, A. J., Voss, C., Mann, J. J., Mason, B. J., Sweeney, J. (1988). Imipramine treatment for chronic depression. Archives of General Psychiatry, 45, 253–257.

    Article  PubMed  Google Scholar 

  • Laborit, H., Huguenard, P., & Alluame, R. (1952). Un neuveau stabilisateur vegetatif (le 4560 RP). Presse Medicale, 60, 206–208.

    PubMed  Google Scholar 

  • Lieberman, J. A., Kane, J. M., & Johns, C. A. (1989). Clozapine: Guidelines for clinical management. Journal of Clinical Psychiatry, 50, 329–338.

    PubMed  Google Scholar 

  • Liebowitz, M. R., Quitkin, F. M., Stewart, J. W., McGrath, P. J., Harrison, W. M., Markowitz, J. S., Rabkin, J. G., Tricamo, E., Goetz, D. M., & Klein, D. F. (1988). Antidepressant specificity in atypical depression. Archives of General Psychiatry, 45, 129–137.

    Article  PubMed  Google Scholar 

  • Maas, J. W., Koslow, S. H., Katz, M. M., Bowden, C. L., Gibbons, R. L., Stokes, P. E., Robbins, E., & Davis, J. M. (1984). Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. American Journal of Psychiatry, 141, 1159–1171.

    PubMed  Google Scholar 

  • McEvoy, J. P., Hogarty, G. E., & Steingard, S. (1991). Optimal dose of neuroleptic in acute schizophrenia: A controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry, 48, 739–745.

    Article  PubMed  Google Scholar 

  • Meijer, J. W. A., Meinardi, H., & Binnie, C. D. (1983). The development of antiepileptic drugs. In M. J. Parnham & J. Bruinvels (Eds.), Discoveries in pharmacology, Vol. I, Psycho-and neuro-pharmacology (pp. 447–488). Amsterdam: Elsevier.

    Google Scholar 

  • Nelson, J. C., Jatlow, P., Quinlan, D. M., & Bowers, M. B. (1982). Desipramine plasma concentration and antidepressant response. Archives of General Psychiatry, 39, 1419–1422.

    Article  PubMed  Google Scholar 

  • Owen, R. T., & Tyrer, P. (1983). Benzodiazepine dependence: A review of the evidence. Drugs, 25, 385–398.

    Article  PubMed  Google Scholar 

  • Pope, H. G., Keck, P. E., McElroy, S. L., Hudson, J. I. (1989). A placebo-controlled study of trazadone in bulimia nervousa. Journal of Clinical Psychopharmacology, 9, 254–259.

    Article  PubMed  Google Scholar 

  • Pope, H. G., McElroy, S. L., Keck, P. E., & Hudson, J. I. (1991). Valproate in the treatment of acute mania: A placebo-controlled study. Archives of General Psychiatry, 48, 62–68.

    Article  PubMed  Google Scholar 

  • Potter, W. Z., Rudorfer, M. V., & Manji, H. (1991). The pharmacologic treatment of depression. New England Journal of Medicine, 325, 633–641.

    Article  PubMed  Google Scholar 

  • Prien, R. F., & Kupfer, D. J. (1986). Continuation of drug therapy for major depressive episodes: How long should it be maintained. American Journal of Psychiatry, 143, 18–23.

    PubMed  Google Scholar 

  • Pryor, T., McGilley, B., & Roach, N. E. (1990). Psychopharmacology and eating disorders: Dawning of a new age. Psychiatric Annals, 20, 711–722.

    Google Scholar 

  • Quitkin, F. M., Rabkin, J. G., Ross, D., & McGrath, P. J. (1984). Duration of antidepressant drug treatment. Archives of General Psychiatry, 41, 238–245.

    Article  PubMed  Google Scholar 

  • Quitkin, F. M., Stewart, J. W., McGrath, P., Liebowitz, M. R., Harrison, W. M., Tricamo, E., Klein, D. F., Rabkin, J. G., Markowitz, J. S., Wager, S. G. (1988). Phenelzine vs. imipramine in probable atypical depression: defining syndrome boundaries of selective MAOI responders. American Journal of Psychiatry, 145, 306–312.

    PubMed  Google Scholar 

  • Rickels, K., Case, W., Schweizer, E. E., Swenson, C, & Fridman, R. B. (1986). Low dose dependence in chronic benzodiazepine users: A preliminary report on 119 patients. Psychopharmacology Bulletin, 22, 407–415.

    PubMed  Google Scholar 

  • Rifkin, A., Doddi, S., Karasgi, B., Borenstein, M., & Wachpress, M. (1991). Dosage of Haloperidol for Schizophrenia. Archives of General Psychiatry, 48, 166–170.

    Article  PubMed  Google Scholar 

  • Risch, S. C., Janowsky, D. S., & Huey, L. Y. (1981). Plasma levels of tricyclic antidepressants and clinical efficacy (pp. 183–217). In Antidepressants: Neurochemical, behavioral and clinical perspectives. New York: Raven Press.

    Google Scholar 

  • Rosenbaum, J. F., & Gelenberg, A. J. (1991). Anxiety. In A. J. Gelenberg & E. L. Bassuk, S. C. Schoonover (Eds.), The practitioner’s guide to psychoactive drugs (3rd ed., pp. 167–201). New York: Plenum.

    Google Scholar 

  • Sachs, G. S. (1989). Adjuncts and alternatives to lithium therapy for bipolar affective disorder. Journal of Clinical Psychiatry, 50 (suppl.), 31–39.

    PubMed  Google Scholar 

  • Sackheim, H. A. (1992). The cognitive effects of electroconvulsive therapy. In L. J. Thal, W. H. Maas, & E. R. Gamzu (Eds.), Cognitive disorders: Pathophysiology and treatment (pp. 183–228). New York: Marcel Dekker.

    Google Scholar 

  • Santos, A. B., & Morton, W. A. (1989). Use of Benzodiazepines to improve management of manic agitation. Hospital and Community Psychiatry, 10, 1069–1071.

    Google Scholar 

  • Schatzberg, A. F. (1988). Depressive disorders. In J. P. Tupin, R. I. Shader, & D. S. Harnett (Eds.), Handbook of clinical psychopharmacology. Northvale, NJ: Jason Aronson.

    Google Scholar 

  • Schatzberg, A. F., & Cole, J. O. (1991). Manual of clinical psychopharmacology. Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Schneider, P. J. (1824). Entwurf zu einer Heilmittellehre gegen psychische Krankheiten—oder Heilmittel in Beziehung auf psychische Krankheitsformen. Tubingen.

    Google Scholar 

  • Shader, R. I. (1988). Stress, fear and anxiety. In J. P. Tupin, R. I. Shader, & D. S. Harnett (Eds.), Handbook of clinical psychopharmacology. Northvale, NJ: Jason Aronson.

    Google Scholar 

  • Shulman, K. I., Walker, S. E., Mackenzie, S., & Knowles, S. (1989). Dietary restriction, tyramine and the use of monoamine oxidase inhibitors. Journal of Clinical Psychopharmacology, 9, 397–402.

    Article  PubMed  Google Scholar 

  • Siris, S. G., & Rifkin, A. (1983). Drug treatment of acute schizophrenia. In A. R. Rifkin (Ed.), Schizophrenia and Affective Disorders, Biology and Drug Treatment. Boston: John Wright.

    Google Scholar 

  • Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, P. (1974). Drugs, neurotransmitters and schizophrenia. Science, 184, 1243–1253.

    Article  PubMed  Google Scholar 

  • Sternbach, L. H. (1972). The discovery of librium. Agents and Actions, 2, 193–196.

    Article  PubMed  Google Scholar 

  • Stewart, J. W., McGrath, P. J., Quitkin, F. M., Harrison, W., Markowitz, J., Wager, S., Liebowitz, M. R. (1989). Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression: Differential response to phenelzine, imipramine and placebo. Archives of General Psychiatry, 46, 1080–1087.

    Article  PubMed  Google Scholar 

  • Strober, M., Morrell, W., Lampert, C., & Burrough, J. (1990). Relapse following discontinuation of lithium maintenance therapy in adolescents with Bipolar illness. A naturalistic study. American Journal of Psychiatry, 147, 457–461.

    PubMed  Google Scholar 

  • Suppesit, Baldessarini, R. J., Faedda, G. L., & Tohen, M. (1991). Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry, 48, 1082–1088.

    Article  PubMed  Google Scholar 

  • Tallarida, R. J. (1985). Most prescribed drugs. Philadelphia: W. B. Saunders.

    Google Scholar 

  • Tallarida, R. J., Raffia, R. B., & McGonigle, P. (1988). Principles in general pharmacology. New York: Springer-Verlag.

    Book  Google Scholar 

  • Van Putten, T., Mutalipassi, L. R., & Malkin, M. O. (1974). Phenothiazine-induced decompensation. Archives of General Psychiatry, 30, 102–106.

    Article  PubMed  Google Scholar 

  • Wager, S. G., & Klein, D. F. (1988). Drug therapy strategies for treatment-resistant depression. Psychopharmacology Bulletin, 24, 69–74.

    PubMed  Google Scholar 

  • Weibert, R. T., & Norcross, W. A. (1988). Drug interactions index. Ordell, NJ: Medical Economics Books.

    Google Scholar 

  • Weiden, P. J., Mann, J. J., & Haas, G. (1987). Clinical non-recognition of neuroleptic-induced movement disorders: A cautionary study. American Journal of Psychiatry, 144, 1148–1153.

    PubMed  Google Scholar 

  • Weilberg, J. B., & Gelenberg, A. J. (1991). Insomnia. In A. J. Gelenberg, E. L. Bassuk, & S. C. Schoonover (Eds.), The Practitioner’s Guide to psychoactive drugs (3rd ed., pp. 219–240). New York: Plenum.

    Chapter  Google Scholar 

  • Zarin, D. A., & Pass, T. M. (1987). Lithium and the single episode: When to begin long term prophylaxis for bipolar disorder. Medical Care, 25, 576–584.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, St. Luke’s-Roosevelt Hospital Center, New York, New York, 10025, USA

    Steven G. Wager

  2. Columbia University College of Physicians and Surgeons, USA

    Steven G. Wager & Gary K. Zammit

  3. Sleep Disorders Institute and Department of Psychiatry, St. Luke’s-Roosevelt Hospital Center, New York, New York, 10025, USA

    Gary K. Zammit

Authors
  1. Steven G. Wager
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary K. Zammit
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Luke’s-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York, USA

    Gary K. Zammit

  2. Department of Psychology, Division of Psychology, Westchester Division, The New York Hospital-Cornell Medical Center, White Plains, New York, 10605, USA

    James W. Hull

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wager, S.G., Zammit, G.K. (1995). Psychopharmacology in Clinical Practice. In: Zammit, G.K., Hull, J.W. (eds) Guidebook for Clinical Psychology Interns. Applied Clinical Psychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0222-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0222-1_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-44859-1

  • Online ISBN: 978-1-4899-0222-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation